Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
74
NCT01403077
480 Biomedical Bioresorbable Scaffold System in the Treatment of de Novo Superficial Femoral Artery (SFA) Lesions
Phase: N/A
Role: Lead Sponsor
Start: Oct 31, 2011
Completion: Oct 31, 2015
NCT02097082
Treatment of SFA Lesions With 480 Biomedical STANZA™ Drug-Eluting Resorbable Scaffold (DRS) System
Start: Oct 31, 2013
Completion: May 31, 2017